l carnitine tmao garlic Gut‒heart axis: emerging therapies targeting trimethylamine N-oxide production Synthesis of TMA and malic

Fosgonimeton failed its Phase 2 ACT-AD trial in 2022 and its Phase 2/3 LIFT-AD trial in September 2024

Conclusion: Central obesity is a significant marker of new-onset albuminuria in individuals with type 1 diabetes on top of established, clinical risk factors and RAAS inhibition

If an underlying primary pathology is responsible, what type of early process could be operating in the area of myelin degeneration that does not exhibit signatures of an autoimmune lymphocytic-driven mechanism, or any detectable infectious or other obvious etiology

Researchers conducting comparative copper-peptide studies in preclinical models typically require accurately stoichiometrically verified material

Made from lipids and sugars, in-vitro studies show glycolipids are a gentle alternative to conventional surfactants